JP2022552834A5 - - Google Patents
Info
- Publication number
- JP2022552834A5 JP2022552834A5 JP2022521147A JP2022521147A JP2022552834A5 JP 2022552834 A5 JP2022552834 A5 JP 2022552834A5 JP 2022521147 A JP2022521147 A JP 2022521147A JP 2022521147 A JP2022521147 A JP 2022521147A JP 2022552834 A5 JP2022552834 A5 JP 2022552834A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- unsubstituted
- substituted
- formula
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962913417P | 2019-10-10 | 2019-10-10 | |
| US62/913,417 | 2019-10-10 | ||
| PCT/US2020/054896 WO2021072140A1 (en) | 2019-10-10 | 2020-10-09 | Prodrugs of myeloperoxidase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022552834A JP2022552834A (ja) | 2022-12-20 |
| JP2022552834A5 true JP2022552834A5 (cg-RX-API-DMAC7.html) | 2023-04-18 |
Family
ID=75438074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521147A Pending JP2022552834A (ja) | 2019-10-10 | 2020-10-09 | ミエロペルオキシダーゼ阻害剤のプロドラッグ |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240067651A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4041735A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022552834A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220080133A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114945573A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020363903A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022006381A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3157260A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL291891A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022004203A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021072140A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022010902A (es) * | 2020-03-05 | 2022-10-07 | Biohaven Therapeutics Ltd | Metodo para tratar la esclerosis lateral amiotrofica con un inhibidor de la mieloperoxidasa. |
| CN115403584B (zh) * | 2021-05-26 | 2024-04-02 | 长春金赛药业有限责任公司 | 2-硫代-2,3-二氢嘧啶-4-酮衍生物、药物组合物及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990012797A1 (en) * | 1989-04-19 | 1990-11-01 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Sulfer-containing xanthine derivatives as adenosin antagonists |
| MY140748A (en) * | 2004-12-06 | 2010-01-15 | Astrazeneca Ab | Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy |
| NZ544187A (en) * | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| WO2007069924A1 (en) * | 2005-12-15 | 2007-06-21 | Industrial Research Limited | Deazapurine analogs of 4'-aza-l-nucleosides |
| US20090054468A1 (en) * | 2007-08-23 | 2009-02-26 | Astrazeneca Ab | New Use 938 |
| NZ604423A (en) * | 2010-06-24 | 2015-01-30 | Alkermes Pharma Ireland Ltd | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| JP6667092B2 (ja) * | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーHydra Biosciences, LLC | ピロロ[3,2−d]ピリミジン−2,4(3H,5H)−ジオン誘導体 |
| DK3265448T3 (da) * | 2015-03-03 | 2022-03-28 | Biohaven Therapeutics Ltd | Riluzol-prodrugs og anvendelse deraf |
| SG11202000086PA (en) * | 2017-07-17 | 2020-02-27 | Astrazeneca Ab | Mpo inhibitors for use in medicine |
-
2020
- 2020-10-09 KR KR1020227015015A patent/KR20220080133A/ko not_active Withdrawn
- 2020-10-09 MX MX2022004203A patent/MX2022004203A/es unknown
- 2020-10-09 AU AU2020363903A patent/AU2020363903A1/en not_active Abandoned
- 2020-10-09 JP JP2022521147A patent/JP2022552834A/ja active Pending
- 2020-10-09 BR BR112022006381A patent/BR112022006381A2/pt not_active IP Right Cessation
- 2020-10-09 IL IL291891A patent/IL291891A/en unknown
- 2020-10-09 US US17/766,539 patent/US20240067651A1/en not_active Abandoned
- 2020-10-09 EP EP20874337.7A patent/EP4041735A4/en not_active Withdrawn
- 2020-10-09 WO PCT/US2020/054896 patent/WO2021072140A1/en not_active Ceased
- 2020-10-09 CN CN202080070666.8A patent/CN114945573A/zh active Pending
- 2020-10-09 CA CA3157260A patent/CA3157260A1/en active Pending